Improving the Gene Ontology Resource to Facilitate More Informative Analysis and Interpretation of Alzheimer’s Disease Data

The analysis and interpretation of high-throughput datasets relies on access to high-quality bioinformatics resources, as well as processing pipelines and analysis tools. Gene Ontology (GO, geneontology.org) is a major resource for gene enrichment analysis. The aim of this project, funded by the Alzheimer’s Research United Kingdom (ARUK) foundation and led by the University College London (UCL) biocuration team, was to enhance the GO resource by developing new neurological GO terms, and use GO terms to annotate gene products associated with dementia. Specifically, proteins and protein complexes relevant to processes involving amyloid-beta and tau have been annotated and the resulting annotations are denoted in GO databases as ‘ARUK-UCL’. Biological knowledge presented in the scientific literature was captured through the association of GO terms with dementia-relevant protein records; GO itself was revised, and new GO terms were added. This literature biocuration increased the number of Alzheimer’s-relevant gene products that were being associated with neurological GO terms, such as ‘amyloid-beta clearance’ or ‘learning or memory’, as well as neuronal structures and their compartments. Of the total 2055 annotations that we contributed for the prioritised gene products, 526 have associated proteins and complexes with neurological GO terms. To ensure that these descriptive annotations could be provided for Alzheimer’s-relevant gene products, over 70 new GO terms were created. Here, we describe how the improvements in ontology development and biocuration resulting from this initiative can benefit the scientific community and enhance the interpretation of dementia data.

[1]  Kristel Sleegers,et al.  Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics. , 2018, Trends in genetics : TIG.

[2]  Bin Hu,et al.  Ontology driven decision support for the diagnosis of mild cognitive impairment , 2014, Comput. Methods Programs Biomed..

[3]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[4]  Marco Masseroli,et al.  Analysis of metabolomic data: tools, current strategies and future challenges for omics data integration , 2016, Briefings Bioinform..

[5]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[6]  Sejal Patel,et al.  Using Gene Ontology to describe the role of the neurexin-neuroligin-SHANK complex in human, mouse and rat and its relevance to autism , 2015, BMC Bioinformatics.

[7]  D. Selkoe,et al.  Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life , 2009, Neurobiology of Disease.

[8]  David M Holtzman,et al.  Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. , 2005, Neuron.

[9]  Weisong Liu,et al.  The Rat Genome Database 2015: genomic, phenotypic and environmental variations and disease , 2014, Nucleic Acids Res..

[10]  A. Draguhn,et al.  Amyloid β Oligomers (Aβ1–42 Globulomer) Suppress Spontaneous Synaptic Activity by Inhibition of P/Q-Type Calcium Currents , 2008, The Journal of Neuroscience.

[11]  M. Hagiwara,et al.  Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly , 2015, Proceedings of the National Academy of Sciences.

[12]  Henning Hermjakob,et al.  The complex portal - an encyclopaedia of macromolecular complexes , 2014, Nucleic Acids Res..

[13]  Guiquan Chen,et al.  A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease , 2000, Nature.

[14]  Denise C. Park,et al.  Beta-Amyloid Deposition and the Aging Brain , 2009, Neuropsychology Review.

[15]  M. Mallar Chakravarty,et al.  Gene Prioritization for Imaging Genetics Studies Using Gene Ontology and a Stratified False Discovery Rate Approach , 2016, Front. Neuroinform..

[16]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[17]  Perry M. Elliott,et al.  Improving Interpretation of Cardiac Phenotypes and Enhancing Discovery With Expanded Knowledge in the Gene Ontology , 2018, Circulation. Genomic and precision medicine.

[18]  K. Yaffe,et al.  The projected effect of risk factor reduction on Alzheimer's disease prevalence , 2011, The Lancet Neurology.

[19]  Fleur Mougin,et al.  Reuse of termino-ontological resources and text corpora for building a multilingual domain ontology: An application to Alzheimer's disease , 2014, J. Biomed. Informatics.

[20]  B. Hyman,et al.  Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions , 2013, Neurobiology of Disease.

[21]  P. Cortelli,et al.  Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study. , 2018, Journal of Alzheimer's disease : JAD.

[22]  Derek H. Oakley,et al.  Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain , 2018, Front. Neurosci..

[23]  Kimberly Van Auken,et al.  A method for increasing expressivity of Gene Ontology annotations using a compositional approach , 2014, BMC Bioinformatics.

[24]  Ira Milosevic Revisiting the Role of Clathrin-Mediated Endoytosis in Synaptic Vesicle Recycling , 2018, Front. Cell. Neurosci..

[25]  Hedi Peterson,et al.  g:Profiler—a web server for functional interpretation of gene lists (2016 update) , 2016, Nucleic Acids Res..

[26]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[27]  Daniele Pepe,et al.  A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia , 2015, Neurobiology of Aging.

[28]  E. Camon,et al.  The Impact of Focused Gene Ontology Curation of Specific Mammalian Systems , 2011, PloS one.

[29]  Rafael C. Jimenez,et al.  The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases , 2013, Nucleic Acids Res..

[30]  Alexander M. Phillips,et al.  Regional protein expression in human Alzheimer’s brain correlates with disease severity , 2018, Communications Biology.

[31]  J. Jia,et al.  An Overview of Genome-Wide Association Studies in Alzheimer’s Disease , 2016, Neuroscience Bulletin.

[32]  Tony Sawford,et al.  Using the Gene Ontology to Annotate Key Players in Parkinson’s Disease , 2016, Neuroinformatics.

[33]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[34]  Kimberly Van Auken,et al.  A guide to best practices for Gene Ontology (GO) manual annotation , 2013, Database J. Biol. Databases Curation.

[35]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[36]  Maria C. Carrillo,et al.  Common Alzheimer’s Disease Research Ontology: National Institute on Aging and Alzheimer’s Association Collaborative Project , 2012, Alzheimer's & Dementia.

[37]  Tony Sawford,et al.  Understanding how and why the Gene Ontology and its annotations evolve: the GO within UniProt , 2014, GigaScience.

[38]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[39]  P. S. St George-Hyslop,et al.  A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. , 2000, Nature.

[40]  The Gene Ontology Consortium Expansion of the Gene Ontology knowledgebase and resources , 2016, Nucleic Acids Res..

[41]  Christine Van Broeckhoven,et al.  The genetic landscape of Alzheimer disease: clinical implications and perspectives , 2015, Genetics in Medicine.

[42]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[43]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[44]  P. Keller,et al.  Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease , 2005 .

[45]  Pascale Gaudet,et al.  The Gene Ontology , 2019, Encyclopedia of Bioinformatics and Computational Biology.

[46]  C. Dobson,et al.  Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease , 2017, Proceedings of the National Academy of Sciences.

[47]  Luc Buée,et al.  What is the evidence that tau pathology spreads through prion-like propagation? , 2017, Acta neuropathologica communications.

[48]  H. Braak,et al.  Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue , 2017, Acta neuropathologica communications.

[49]  Emily Perry,et al.  The Ensembl Genome Browser: Strategies for Accessing Eukaryotic Genome Data. , 2018, Methods in molecular biology.

[50]  A. Palmeri,et al.  Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.

[51]  Val Lowe,et al.  Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. , 2013, Brain : a journal of neurology.

[52]  S. Younkin,et al.  The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  Elspeth A. Bruford,et al.  Genenames.org: the HGNC resources in 2015 , 2014, Nucleic Acids Res..

[54]  D. Forero,et al.  Functional genomics of candidate genes derived from genome-wide association studies for five common neurological diseases , 2017, The International journal of neuroscience.

[55]  Young Mok Park,et al.  Proteogenomics of the human hippocampus: The road ahead. , 2015, Biochimica et biophysica acta.

[56]  Rachael P. Huntley,et al.  QuickGO: a web-based tool for Gene Ontology searching , 2009, Bioinform..

[57]  Fei Liu,et al.  Tau in Alzheimer disease and related tauopathies. , 2010, Current Alzheimer research.

[58]  George A. Carlson,et al.  The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[59]  F. Kametani,et al.  Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease , 2018, Front. Neurosci..

[60]  M. Rattray,et al.  Gene expression profiling in human neurodegenerative disease , 2012, Nature Reviews Neurology.

[61]  Maria C. Carrillo,et al.  International Alzheimer's Disease Research Portfolio (IADRP) aims to capture global Alzheimer's disease research funding , 2014, Alzheimer's & Dementia.

[62]  A. Salminen,et al.  Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases , 2014, Ageing Research Reviews.

[63]  N. Hooper,et al.  Amyloid-β Receptors: The Good, the Bad, and the Prion Protein* , 2015, The Journal of Biological Chemistry.

[64]  J. Schott,et al.  Inflammation in Alzheimer's disease: insights from immunotherapy. , 2013, Brain : a journal of neurology.

[65]  D. Butterfield,et al.  Amyloid β‐Peptide(1‐42) Contributes to the Oxidative Stress and Neurodegeneration Found in Alzheimer Disease Brain , 2004, Brain pathology.

[66]  B. Zlokovic,et al.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. , 2016, Biochimica et biophysica acta.

[67]  B. Hyman,et al.  Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  Linda J. C. van Waalwijk van Doorn,et al.  Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers. , 2018, Journal of Alzheimer's disease : JAD.

[70]  Alex Bateman,et al.  RNAcentral: a hub of information for non-coding RNA sequences , 2018, Nucleic Acids Res..

[71]  Joanne L Welton,et al.  Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis , 2017, Journal of extracellular vesicles.

[72]  P. Keller,et al.  Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. , 2005, Journal of neurochemistry.

[73]  M. Shelanski,et al.  Neurogenic Effect of β-Amyloid Peptide in the Development of Neural Stem Cells , 2004, The Journal of Neuroscience.

[74]  Hilla Peretz,et al.  The , 1966 .

[75]  Gang Fu,et al.  Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data , 2014, Nucleic Acids Res..

[76]  Henning Hermjakob,et al.  Complex Portal 2018: extended content and enhanced visualization tools for macromolecular complexes , 2018, Nucleic Acids Res..

[77]  Prudence Mutowo-Meullenet,et al.  The GOA database: Gene Ontology annotation updates for 2015 , 2014, Nucleic Acids Res..

[78]  Martin Hofmann-Apitius,et al.  ADO: A disease ontology representing the domain knowledge specific to Alzheimer's disease , 2014, Alzheimer's & Dementia.

[79]  S. Bicciato,et al.  Regeneration of the entire human epidermis using transgenic stem cells , 2017, Nature.

[80]  Perry G. Ridge,et al.  Bridging the Gap between Statistical and Biological Epistasis in Alzheimer's Disease , 2015, BioMed research international.

[81]  Wendy Noble,et al.  Roles of tau protein in health and disease , 2017, Acta Neuropathologica.

[82]  H. Braak,et al.  Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART , 2018, Acta Neuropathologica.

[83]  Carol J. Bult,et al.  Visual annotation display (VLAD): a tool for finding functional themes in lists of genes , 2015, Mammalian Genome.

[84]  Kristel Sleegers,et al.  Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond , 2016, The Lancet Neurology.

[85]  Sangya Pundir,et al.  UniProt Tools , 2016, Current protocols in bioinformatics.

[86]  K. Imahori,et al.  Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease Brains* , 2009, The Journal of Biological Chemistry.

[87]  The Gene Ontology Consortium,et al.  Expansion of the Gene Ontology knowledgebase and resources , 2016, Nucleic Acids Res..

[88]  R. Malenka,et al.  Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms , 2008, Neuropsychopharmacology.

[89]  Tatiana A. Tatusova,et al.  Gene: a gene-centered information resource at NCBI , 2014, Nucleic Acids Res..

[90]  Ruth C Lovering,et al.  Exploring autophagy with Gene Ontology , 2016, Autophagy.

[91]  Amaia M. Arranz,et al.  Hallmarks of Alzheimer’s Disease in Stem-Cell-Derived Human Neurons Transplanted into Mouse Brain , 2017, Neuron.

[92]  B. Hyman,et al.  Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo , 2012, Nature Communications.

[93]  J. Gallacher,et al.  Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing , 2018, bioRxiv.

[94]  M. Shelanski,et al.  Neurogenic effect of beta-amyloid peptide in the development of neural stem cells. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[95]  Michelle K. Lupton,et al.  ABCA7 p.G215S as potential protective factor for Alzheimer's disease , 2016, Neurobiology of Aging.

[96]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[97]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[98]  Peter N. Robinson,et al.  Clinical phenotype-based gene prioritization: an initial study using semantic similarity and the human phenotype ontology , 2014, BMC Bioinformatics.

[99]  Shigeki Watanabe,et al.  Synaptic Vesicle Endocytosis in Different Model Systems , 2018, Front. Cell. Neurosci..

[100]  Chris Mungall,et al.  AmiGO: online access to ontology and annotation data , 2008, Bioinform..

[101]  Ralph A. Nixon,et al.  Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.

[102]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[103]  Rachael P. Huntley,et al.  QuickGO: a user tutorial for the web-based Gene Ontology browser , 2009, Database J. Biol. Databases Curation.

[104]  B. Barres,et al.  Microglia and macrophages in brain homeostasis and disease , 2017, Nature Reviews Immunology.

[105]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[106]  Giulia Antonazzo,et al.  FlyBase 2.0: the next generation , 2018, Nucleic Acids Res..